NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/24/2023
Back to search
Official data from USPTO
R
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
01/24/2023
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
12/31/2021
Registration date
01/24/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2023
Last transaction
01/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/10/2021
First use in commerce
05/10/2021
Drawing code
5
Owner type
03
Owner location
Foster City, CA
Examiner
LOVELACE, JAMES
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized letter "R" sharing a stroke "|" with a stylized upside-down inverted "R", where the stylized letter "R" has two openings between the stroke "|" and the right part of "R" and the stylized upside-down inverted "R" has two openings between the stroke "|" and the left part of the upside-down inverted "R".
Holders and representatives
Holders
Revir Therapeutics, Inc.
Representatives
Enshan Hong MAGSTONE LAW, LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services; Medical consulting services in the field of disease infection control; Providing medical care services and consultation related thereto; Pharmaceutical and medical consultancy; Providing healthcare information and advisory services in the healthcare field; Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; Medical services, namely, providing therapies for treating proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases and neurodegenerative disease; Medical services, namely, providing therapeutic and prophylactic treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases, and neurodegenerative disease; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/05/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/05/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/05/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/05/2022
DOCK
ASSIGNED TO EXAMINER
10/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/01/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/05/2022
NWAP
NEW APPLICATION ENTERED
01/04/2022
Continuous trademark protection
Get notified about every new filing that threatens R or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.